Examining the immune system’s response to disease has been a hot new area in diagnostics – particularly when done with a single drop of blood, as has been widely publicized with the ever-evasive Theranos. Arizona startup HealthTell studies the immunosignatures found in small samples of blood to suss out whether a patient has certain cancers, autoimmune and infectious disease.
While Theranos’ methodology is cloaked in secrecy, HealthTell is making it a point to emphasize its transparency.
Hey, check out all the engineering jobs. Post your resume today!
